General Archive
-
News releasesRepurposing drugs: the opportunity and the challenges
Sign up for our seminar on intellectual property, regulation, commercial positioning and patient involvement.
-
News releasesLifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC…
-
News releasesLifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
LifeArc announced today a £10 million cornerstone investment in the funding cycle of Illumina Accelerator Cambridge. This is part of…
-
News releasesLifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging research that could…
-
News releasesMetrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical…
-
News releasesLifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre…
-
News releasesLifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the development of novel…
-
News releasesLifeArc and Cleveland Clinic collaborate to advance early stage research towards patients
LifeArc to fund two post-doctoral fellowships focused on drug discovery In November 2020, LifeArc initiated a new strategic collaboration with…
-
News releasesKQ Labs Accelerator welcomes 10 innovative start-ups
KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick Institute and now funded by LifeArc,…
-
News releasesUK DRI appoints LifeArc to support translation of discoveries into treatments
LifeArc has been appointed by the UK Dementia Research Institute (UK DRI) to provide expertise to accelerate the translation of…
-
News releasesLifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics
Funding to help drive the development of new cancer therapies
-
News releasesBiocartis expands collaboration with LifeArc
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the expansion of…